MORRISVILLE, N.C. and PALO ALTO, Calif., Jan. 30 /PRNewswire/ -- Diagnosoft, Inc., an innovator in magnetic resonance (MR) image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease, has unveiled its newest software solution: Diagnosoft(R) SENC. Strain-encoding, or SENC, is a new MRI analysis technique that will help physicians measure regional contraction, or relaxation, of the heart's myocardium. Like Diagnosoft's other two software products, Diagnosoft(R) HARP(TM) and Diagnosoft(R) PLUS, Diagnosoft(R) SENC enables quantification of data to improve diagnosis and guide monitoring and treatment of coronary artery disease.
Developed by Dr. Nael Osman, a faculty member at
Most cardiac MRI procedures require patients to hold their breath. However, SENC images can be acquired in a fraction of a second, mapping regional function with unprecedented speed, so it can be used in combination with tests and maneuvers that allow patients to breathe normally. That means SENC is suitable for stress testing of cardiac function, as well as other diagnostic tests.
Dr. Osman said new Diagnosoft(R) SENC is a great addition to a rich and unique product suite originated with Diagnosoft(R) HARP(TM), "While MR tagged images can be produced on most MRI systems, this pulse sequence has limited spatial resolution and takes time to acquire. SENC pulse sequence does not require a second step of image processing, as does analyzing tagged MR images, so it streamlines throughput and decision-making."
Diagnosoft, Inc., based in North Carolina and California, is a privately held company specializing in image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease. One of its products, Diagnosoft HARP(TM), is distinguished as the first FDA 510k-cleared software designed for the analysis of tagged magnetic resonance images. The company is focused on improving physician workflow, quantifying decision-making, and enhancing research and drug development advances.
Company founders Dr. Nael Osman and Dr. Jerry Prince, developed HARP technology at
Diagnosoft(R) is a registered trademark of Diagnosoft, Inc. HARP(R) is a registered trademark of Johns Hopkins University. Diagnosoft, Inc. disclaims any proprietary interest in the marks and names of others.
Contact: Firas BenAchour 1-919-388-9492
|SOURCE Diagnosoft, Inc.|
Copyright©2009 PR Newswire.
All rights reserved